When studying the influence of ANXA1 silencing on the SCLC tumor cell biology, we found that, despite discrete biological changes in particular cell lines, we could not identify any unequivocal and universal effects that would warrant the development of targeted therapies against this specific molecule. Here, ANXA1 is linked to small cell lung carcinoma.